· rebuilt nightly from public records
Signal Sheet
Reprise Biomedical is a private biotechnology company in Plymouth, Minnesota. It raised $1.4M in May 2026 and its filings name 13 officers. Everything below links to the record it came from.
Equity raise reported to the SEC, May 2026.
CapitalPick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.
Want this matched to what you sell? Get early access to Pursuit Plans →The most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| May 14, 2026 | Raised $9.2M in equity from 43 investors | Capital | SEC filing |
| May 14, 2026 | Raised $1.4M in equity from 4 investors | Capital | SEC filing |
| Jun 26, 2025 | Raised $6.4M in equity from 14 investors | Capital | SEC filing |
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Carrie Powers | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Jake Isenburg | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Tom Kouchoukos | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Steve Jagodzinski | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Greg Smock | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Jerrod Krueger | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Heather Kotila | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Jeff Duncan | SEC filing, May 2026 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Howard Root | SEC filing, May 2026 | Technology and tooling decisions |
| Chief Technology Officer | Ronald Eibensteiner | SEC filing, May 2026 | Technology and tooling decisions |
| Chief Technology Officer | Erwin Kelen | SEC filing, May 2026 | Technology and tooling decisions |
| Chief Technology Officer | Phil Nalbone | SEC filing, May 2026 | Technology and tooling decisions |
| Chief Technology Officer | Alan Woldt | SEC filing, May 2026 | Technology and tooling decisions |
Lakewave does the research, the stitching and the first draft with AI, so you spend your time selling.
Lakewave tracks raises, new leaders, hiring and filings across your accounts and territory, and tells you the day something changes.
Find the decision makers, get mailbox-verified addresses and an AI draft written for that account, which you review. Send from your own inbox with open and reply tracking and a follow-up sequence.
Which accounts to pursue, why now, who to reach and what to say, matched to your product and the buyers you sell to.
Every address Lakewave gives you is checked against Reprise Biomedical's mail server before you see it. Guessed addresses bounce, and bounces are what push a sender's domain toward the spam folder, so one bad list can cost a rep weeks of deliverability. Lakewave shows how each address was confirmed and leaves out the ones it cannot verify.
Use it two ways. Look up the verified address you need for a call you are already planning. Or let Lakewave do the whole job: find the accounts with a reason to buy now, the right people and their addresses, and draft a first email for each person, so you are not stitching together data sources and research by hand.
Try it on Reprise Biomedical with a free trial →| Headquarters | Plymouth, Minnesota, per the filing address |
| Industry group | Biotechnology |
| Ownership | Private company |
| Raise history | $6.4M (Jun 2025) · $1.4M (May 2026) |
| Lakewave Rising | 7 · 1 kinds of evidence · rank in Minnesota after sign-up |
Yes. Reprise Biomedical reported a $1.4M equity raise to the SEC on May 14, 2026 with 43 investors.
The company's SEC filing, May 2026 names Carrie Powers (Executive Officer) among its officers.
Plymouth, Minnesota, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialEvery account you select comes back scored by what changed this month, with the source for each fact.
Named officers from filings and announcements, each with an address verified against the mailbox. No bounces, no guessed patterns, no scraped profiles.
Lakewave writes a first email for each person, tailored to their role and company. You edit, approve and send it from your own mailbox.
A weekly note on what changed across your targets, so no account moves without you knowing.
Free trial · No credit card · Built from public records, refreshed nightly
Compiled from public records and refreshed nightly; last updated Nov 10, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.